⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10040942 | 1.00 | — | — | |
| SCHEMBL328714 | 1.00 | — | — | |
| SCHEMBL10062345 | 1.00 | — | — | |
| SCHEMBL14726014 | 1.00 | — | — | |
| SCHEMBL12238862 | 1.00 | — | — | |
| SCHEMBL16784861 | 1.00 | — | — | |
| SCHEMBL6468464 | 1.00 | — | — | |
| SCHEMBL5570919 | 1.00 | — | — | |
| SCHEMBL17814231 | 0.84 | — | — | |
| SCHEMBL20845805 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8728515-B2 | Adjuvants for use in vaccination | BANGOR UNIVERSITY (GB) | 2014-05-20 | — | — | US | disclosed |
| EP-1808490-B1 | Genetically engineered bleb vaccine | GLAXOSMITHKLINE BIOLOG SA (BE) | 2012-11-14 | — | — | EP | disclosed |
| US-20120110688-A1 | AAD-12 EVENT 1606 AND RELATED TRANSGENIC SOYBEAN LINES | DOW AGROSCIENCES LLC (US) | 2012-05-03 | — | — | US | disclosed |
| US-7598287-B2 | Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities | MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC. (US) | 2009-10-06 | — | — | US | disclosed |